Michael Rosenblatt - Merck Insider

Merck Co Inc -- USA Stock  

USD 55.2  0.03  0.0544%

Executive Vice President Chief Medical Officer

Dr. Michael Rosenblatt, M.D., is Executive Vice President, Chief Medical Officer of Merck Co., Inc. He is responsible for the Companys primary voice to the global medical community on critical issues such as patient safety and oversight for the Companys Global Center for Scientific Affairs. Prior to December 2009, Dr. Rosenblatt was the Dean of Tufts University School of Medicine since 2003.
Age: 67  President Since 2009  Ph.D    
908 735-1500  www.merck.com

Michael Rosenblatt Latest Insider Activity

Management Efficiency

The company has Return on Asset of 7.18 % which means that on every $100 spent on asset it made $7.18 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 12.29 % implying that it generated $12.29 on every 100 dollars invested.
The company has 24.91 B in debt with debt to equity (D/E) ratio of 62.7 . This implies that the company may be unable to create cash to meet all of its financial commitments. Merck Co Inc has Current Ratio of 1.47 which is typical for the industry and considered as normal.

Similar Executives

Showing few of many executives

PRESIDENT Since

Philippe SchaisonAllergan plc
2015
Brian LortieEndo International plc
N/A
James ErlingerQuintiles IMS Holdings Inc
2013
Kevin KnightlyQuintiles IMS Holdings Inc
2016
Roger BirdAbbott Laboratories
2015
Michael CrowleyBio Rad Laboratories Inc
2014
Robert StewartAllergan plc
2016
Joseph ManningAbbott Laboratories
2017
Blaise ColemanEndo International plc
2016
Jared WatkinAbbott Laboratories
2015
Charles FoltzAbbott Laboratories
2013
Robert FordAbbott Laboratories
2015
Thomas FrinziAbbott Laboratories
2016
Ian SmithVertex Pharmaceuticals Incorpor
2017
Michael PariniVertex Pharmaceuticals Incorpor
2017
Deepak NathAbbott Laboratories
2015
Ronald HuttonBio Rad Laboratories Inc
2012
Shawn SoderbergBio Rad Laboratories Inc
2013
William MeuryAllergan plc
2016
Paul NavarreAllergan plc
Murthy SimhambhatlaAbbott Laboratories
2013

Entity Summary

Merck & Co., Inc. offer healthcare solutions worldwide. Merck Co Inc (MRK) is traded on New York Stock Exchange in USA. It is located in NEW JERSEY, U.S.A and employs 66,645 people. Merck is listed under Pharmaceutical Products category by Fama And French industry classification.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Merck Co Inc to your portfolio

Top Management

Merck Co Inc Leadership Team
Thomas Glocer, Director
C Kidder, Director
Craig Thompson, Director
Rochelle Lazarus, Director
Michael Rosenblatt, President, Ph.D
Wendell Weeks, Director
Michael Holston, President
Paul Rothman, Director
Adele Ambrose, President
Joseph Romanelli, Executive
Mirian GraddickWeir, President, Ph.D
Peter Wendell, Director
Leslie Brun, Director
Julie Gerberding, President
Pamela Craig, Director, MBA
Patricia Russo, Director
Willie Deese, President
Rita Karachun, SVP
Robert Davis, CFO
Robert Kidder, Director
Thomas Cech, Director, Ph.D
Clark Golestani, EVP
William Harrison, Director
Roger Perlmutter, President, Ph.D
Sanat Chattopadhyay, President
Adam Schechter, President
Carlos Represas, Director
Richard DeLuca, President
Kenneth Frazier, Chairman

Stock Performance

Merck Performance Indicators